Announcements
- Coloplast A/S - Announcement no. 07/2022 - Interim Financial Report, 9M 2021/2022
- Coloplast A/S - Selskabsmeddelse nr. 07/2022 - Regnskabsmeddelelse, 9M 2021/2022
- Coloplast awarded AscenDrive Agreement for Ostomy Products with Premier, Inc.
- Nueva web informative sobre la cirugía del cancer de laringe
- Nouveau site internet d’informations sur la chirurgie du cancer du larynx
- New informational website around larynx cancer surgery
- Selskabsmeddelelse nr. 06/2022 - Coloplast offentliggør obligationsudstedelse på EUR 2,2 mia. som led i selskabets Euro Medium Term Note-program
- Announcement no. 06/2022 - Coloplast announces the successful issuance of EUR 2.2 billion senior notes under its Euro Medium Term Note programme
- Selskabsmeddelelse nr. 05/2022 - Coloplast offentliggør etableringen af selskabets Euro Medium Term Note-program
- Announcement no. 05/2022 - Coloplast announces the establishment of its Euro Medium Term Note programme
More ▼
Key statistics
On Wednesday, Coloplast A/S (0QBO:LSE) closed at 879.50, 20.55% above the 52 week low of 729.60 set on Jun 16, 2022.
52-week range
Markit short selling activity
Open | 833.80 |
---|---|
High | 904.60 |
Low | 837.20 |
Bid | 861.60 |
Offer | 897.40 |
Previous close | 879.50 |
Average volume | 66.28k |
---|---|
Shares outstanding | 198.00m |
Free float | 108.92m |
P/E (TTM) | 38.13 |
Market cap | 168.06bn DKK |
EPS (TTM) | 22.26 DKK |
Annual div (ADY) | 19.00 DKK |
---|---|
Annual div yield (ADY) | 2.16% |
Div ex-date | May 09 2022 |
Div pay-date | May 11 2022 |
Data delayed at least 20 minutes, as of Aug 17 2022 17:43 BST.
More ▼